Siemens
Aitiologic Developing Liquid Biopsy Assay for Tissue-of-Origin Analysis, Early Disease Detection
Premium
The Austrian startup's assay and software, which are early in R&D, promise to profile both the genetic and epigenetic signatures of cell-free DNA from blood samples.
Liquid Biopsy Startup Aitiologic Launches With €2.5M in Private-Public Funding
The company said it is commercializing a cell-free DNA assay based on a proprietary technology developed by a company cofounder at Siemens Healthineers.
At the ADLM annual meeting, firms said they see game-changing opportunities for platforms that provide the right combination of clinical utility and convenience.
Top Five Articles on GenomeWeb Last Week: Singular Genomics, Illumina, Siemens Healthineers, More
Last week, GenomeWeb's readers were most interested in layoffs at Singular Genomics.
With Exit From PCR Business, Siemens Healthineers Narrows Focus of Remaining Molecular Tools
Premium
With this week's announced closure of its Fast Track Diagnostics business, the firm is focusing on its lineup of non-molecular instruments and assays.
May 11, 2022
Sep 25, 2019